Anti-PKMYT1 antibody [EPR27155-51] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal PKMYT1 antibody. Carrier free. Suitable for IP, ICC/IF, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
MYT1, PKMYT1, Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase, Myt1 kinase
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PKMYT1 antibody [EPR27155-51] - BSA and Azide free (AB307147)
This data was developed using ab307146, the same antibody clone in a different buffer formulation. Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeABilized K-562 (human chronic myelogenous leukemia lymphoblast) cells lABelling PKMYT1 with ab307146 at 1/50 (10.42 ug/ml) dilution, followed by ab150081 Goat Anti-RABbit IgG H&L (Alexa Fluor? 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing cytoplasmic staining in K-562 cell line.Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor? 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-RABbit IgG H&L (Alexa Fluor? 488) preadsorbed at 1/1000 2 ug/ml dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-PKMYT1 antibody [EPR27155-51] - BSA and Azide free (AB307147)
This data was developed using ab307146, the same antibody clone in a different buffer formulation.
PKMYT1 was immunoprecipitated from 0.35 mg K562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate 10 ug with ab307146 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab307146 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : K562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate 10 ug
Lane 2 : ab307146 IP in K562 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab307146 in K562 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds
All lanes:
Immunoprecipitation - Anti-PKMYT1 antibody [EPR27155-51] (<a href='/en-us/products/primary-antibodies/pkmyt1-antibody-epr27155-51-ab307146'>ab307146</a>) at 1/1000 dilution
Lane 1:
K562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate 10 μg
Lane 2:
K562 whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 60 kDa,70 kDa
false
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-PKMYT1 antibody [EPR27155-51] - BSA and Azide free (AB307147)
This data was developed using 307146, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : The molecular weight observed is consistent with what has been described in the literature (PMID : 9268380). Nocodazole treatment results in PKMYT1 phosphorylation and a shift of MW on the gel. Lanes 1-2 : 81 seconds, Lane 3 : 26 seconds. Exposure time :
All lanes:
Western blot - Anti-PKMYT1 antibody [EPR27155-51] (<a href='/en-us/products/primary-antibodies/pkmyt1-antibody-epr27155-51-ab307146'>ab307146</a>) at 1/1000 dilution
Lane 1:
Untreated K562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate 20 μg
Lane 2:
K562 treated with /mL nocodazole for 18 hours whole cell lysate 13 μg
Lane 3:
Untreated CCRF-CEM (human peripheral blood T lymphoblast) whole cell lysate 20 μg
Lane 4:
CCRF-CEM treated with /mL nocodazole for 18 hours whole cell lysate 20 μg
Lane 5:
K562 whole cell lysate 20 μg
Lane 6:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 20 μg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Observed band size: 60 kDa,70 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-PKMYT1 antibody [EPR27155-51] - BSA and Azide free (AB307147)
This data was developed using 307146, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 62 seconds Exposure time :
All lanes:
Western blot - Anti-PKMYT1 antibody [EPR27155-51] (<a href='/en-us/products/primary-antibodies/pkmyt1-antibody-epr27155-51-ab307146'>ab307146</a>) at 1/1000 dilution
Lane 1:
K-562 (human chronic myelogenous leukemia lymphoblast) transfected with scrambled siRNA control whole cell lysate 20 μg
Lane 2:
K-562 transfected with siRNA specifically targeti PKMYT1 whole cell lysate 20 μg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 60 kDa,70 kDa
false
Exposure time: 62s
- WB
Lab
Western blot - Anti-PKMYT1 antibody [EPR27155-51] - BSA and Azide free (AB307147)
This data was developed using ab307146, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time :
Lane 1 : 60 seconds
Lane 2 : 73 seconds
MYT1 is a regulator during mitosis, it may shift to different migrating forms in mitotic lysates causing different observed band sizes. PMID : 23241949, PMID : 9268380)
All lanes:
Western blot - Anti-PKMYT1 antibody [EPR27155-51] (<a href='/en-us/products/primary-antibodies/pkmyt1-antibody-epr27155-51-ab307146'>ab307146</a>) at 1/1000 dilution
Lane 1:
SH-SY5Y (Human neuroblastoma epithelial cell) whole cell lysate (batch 1) at 20 µg
Lane 2:
SH-SY5Y (Human neuroblastoma epithelial cell) whole cell lysate (batch 2) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 55 kDa
Observed band size: 45-70 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This kinase is involved in controlling cell division essential for maintaining genomic integrity. PKMYT1 although not always a direct part of a physical complex significantly impacts the activation of CDK1-cyclin B complex which initiates mitosis. By phosphorylating the CDK1 complex PKMYT1 ensures proper timing of cell cycle transitions preventing premature or erroneous mitotic entry.
Pathways
PKMYT1 involvement is notable in the cell cycle regulation specifically during the G2/M transition. PKMYT1 phosphorylates CDK1 inhibiting its activity until the cell is ready to progress into mitosis. Related proteins in this pathway include CDC25 a phosphatase that removes the inhibitory phosphate groups from CDK1 allowing progression to mitosis. Through these interactions PKMYT1 tightly regulates the commitment to mitosis ensuring cells divide accurately.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Molecular therapy. Nucleic acids 36:102610 PubMed40673159
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com